| 000 | 01282 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250512114335.0 | ||
| 264 | 0 | _c19731212 | |
| 008 | 197312s 0 0 eng d | ||
| 022 | _a0008-4409 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZeldowicz, L R | |
| 245 | 0 | 0 |
_aLong-term therapy of Parkinson's disease with amantadine, alone and combined with levodopa. _h[electronic resource] |
| 260 |
_bCanadian Medical Association journal _cOct 1973 |
||
| 300 |
_a588-93 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aActivities of Daily Living |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAmantadine _xadministration & dosage |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aDihydroxyphenylalanine _xadministration & dosage |
| 650 | 0 | 4 | _aEvaluation Studies as Topic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMotor Skills _xdrug effects |
| 650 | 0 | 4 | _aNeurologic Examination |
| 650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aHubermann, J | |
| 773 | 0 |
_tCanadian Medical Association journal _gvol. 109 _gno. 7 _gp. 588-93 |
|
| 999 |
_c4586621 _d4586621 |
||